Long-Term Relationships: the Complicated Interplay between the Host and the Developmental Stages of Toxoplasma gondii during Acute and Chronic Infections

Microbiology and Molecular Biology Reviews : MMBR
Kelly J Pittman, Laura Knoll

Abstract

Toxoplasma gondii represents one of the most common parasitic infections in the world. The asexual cycle can occur within any warm-blooded animal, but the sexual cycle is restricted to the feline intestinal epithelium. T. gondii is acquired through consumption of tissue cysts in undercooked meat as well as food and water contaminated with oocysts. Once ingested, it differentiates into a rapidly replicating asexual form and disseminates throughout the body during acute infection. After stimulation of the host immune response, T. gondii differentiates into a slow-growing, asexual cyst form that is the hallmark of chronic infection. One-third of the human population is chronically infected with T. gondii cysts, which can reactivate and are especially dangerous to individuals with reduced immune surveillance. Serious complications can also occur in healthy individuals if infected with certain T. gondii strains or if infection is acquired congenitally. No drugs are available to clear the cyst form during the chronic stages of infection. This therapeutic gap is due in part to an incomplete understanding of both host and pathogen responses during the progression of T. gondii infection. While many individual aspects of T. gondii infect...Continue Reading

References

Jul 1, 1992·Parasite Immunology·C A HunterJ Alexander
Aug 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B J Luft, J S Remington
Apr 1, 1985·Annals of Tropical Medicine and Parasitology·H H Stibbs
Nov 30, 1988·Biochemical and Biophysical Research Communications·J B HibbsE M Rachlin
Sep 1, 1969·Proceedings of the Society for Experimental Biology and Medicine·J S Remington, T C Merigan
Oct 1, 1970·The Journal of Experimental Medicine·J P DubeyJ K Frenkel
Feb 1, 1972·The Journal of protozoology·J P Dubey, J K Frenkel
Jan 1, 1971·The Journal of Infectious Diseases·L O Gentry, J S Remington
Feb 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·E R Pfefferkorn
May 15, 1982·Cellular Immunology·W E HauserJ S Remington
Jun 1, 1980·Annals of Tropical Medicine and Parasitology·W M HutchinsonJ Hay
Dec 1, 1995·The Journal of Infectious Diseases·D K Howe, L D Sibley
May 1, 1994·Infection and Immunity·I A KhanL H Kasper
Jan 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J McAuleyW Schey
Jul 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·R T GazzinelliA Sher
Nov 1, 1993·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D M Israelski, J S Remington
May 1, 1993·Clinical Immunology and Immunopathology·C C ChaoP K Peterson
Jan 1, 1996·American Journal of Ophthalmology·C A McCannelT G Rimmer
Jun 1, 1996·American Journal of Ophthalmology·J Freedman
May 23, 1996·European Journal of Pharmacology·S Kaur, M Starr
Sep 1, 1995·Research in Immunology·T Scharton-KerstenA Sher
Dec 1, 1996·Epidemiology and Infection·S PalmerP Thomas
Jun 1, 1997·Journal of Neuroimmunology·M Deckert-SchlüterD Schlüter
Nov 14, 1997·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·J C BoothroydS Tomavo

❮ Previous
Next ❯

Citations

Mar 1, 2016·Neuropharmacology·Nicholas H HuntHelen J Ball
Apr 30, 2016·Current Opinion in Microbiology·Urs B Müller, Jonathan C Howard
Jul 6, 2016·Mediators of Inflammation·Sheryl L Coutermarsh-OttIrving C Allen
Jul 28, 2016·Cellular Microbiology·Nathaniel G JonesL David Sibley
Sep 8, 2016·Antimicrobial Agents and Chemotherapy·Madalyn M McFarlandPaul H Davis
Nov 25, 2018·Parasite Immunology·Margarida BorgesCraig W Roberts
Jan 31, 2020·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jin-Lei WangXing-Quan Zhu
Jun 13, 2020·The FEBS Journal·Joachim KloehnDominique Soldati-Favre
Jul 7, 2017·Frontiers in Cellular and Infection Microbiology·Aindrila BiswasIldiko Rita Dunay
Dec 7, 2018·Frontiers in Microbiology·Jing YangRui Fang
Sep 12, 2020·Parasitology Research·Zhong-Yuan LiQuan Liu
Feb 14, 2017·Current Clinical Microbiology Reports·Anthony P SinaiAbhijit Patwardhan
Mar 1, 2017·Frontiers in Immunology·Yuanling LiJilong Shen
May 26, 2017·Journal of Enzyme Inhibition and Medicinal Chemistry·Simone CarradoriLorraine Jones-Brando
Aug 22, 2020·Emerging Microbes & Infections·Hyang-Hee SeoJung-Hyun Kim
Jan 15, 2021·Scientific Reports·Ahmed M ShammaaImaan Benmerzouga
Nov 19, 2020·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Do-Won HamEun-Hee Shin
Mar 5, 2021·Frontiers in Immunology·Mariana BarrosMargarida Borges
Feb 3, 2021·Infection and Immunity·Patrick W CervantesLaura J Knoll
Jun 14, 2021·Food Microbiology·Emily L Lilly, Nathan J Webster
Mar 29, 2019·Pteridines·Celine C CoronaTeodor T Postolache
Aug 15, 2021·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Ali AsghariAmir Abdoli
Dec 19, 2020·ACS Medicinal Chemistry Letters·Muhammad M KhalifaJennifer E Golden
Aug 1, 2019·Journal of Agricultural and Food Chemistry·Hong-Yan GuoZhe-Shan Quan
Aug 27, 2021·Metabolites·Joachim KloehnDominique Soldati-Favre

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier & Cytokines

Some cytokines are able to cross the blood brain barrier through transport systems and enter the cerebrospinal fluid and interstitial fluid spaces. Here is the latest research on cytokines crossing the blood brain barrier and how this can affect tissues within the CNS.